USE OF WHOLE PROTEIN SUPPLEMENT AS AN ADJUNCT IN INSULIN COMA THERAPY
Abstract
A study with the use of a whole protein supplement and dextrose solution administered orally or by intubation as an adjunct in interruption of insulin coma was conducted to determine if this procedure was more efficacious in reducing the frequency and severity of delayed adverse reactions than the administration of a 50% dextrose solution alone for interruption.
Results of study indicate that delayed adverse reactions were reduced approximately by one-half with the whole protein supplement procedure.
There is not much difference in the amount of intravenous medications required in either procedure, both in the insulin department or on the wards, because of patients' refusal or inability to eat lunch.
The patients themselves greatly preferred the whole protein supplement to the dextrose solution and it seemed to satisfy their hunger. Also, much less vomiting was noted in patients receiving the whole protein supplement.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
